Flavonoid derivative (Fla-CN) inhibited adipocyte differentiation via activating AMPK and up-regulating microRNA-27 in 3T3-L1 cells

Flavonoid derivative (Fla-CN) inhibited adipocyte differentiation via activating AMPK and up-regulating microRNA-27 in 3T3-L1 cells
复制标题

类黄酮衍生物 (Fla-CN) 通过激活 AMPK 和上调 3T3-L1 细胞中的 microRNA-27 抑制脂肪细胞分化

DOI:
10.1016/j.ejphar.2017.01.009
复制
发表时间:
2017-02-15
影响因子:
5
通讯作者:
Duan, Hong-Quan
Duan, Hong-Quan
中科院分区:
医学2区
文献类型:
--
作者:
Gan, Chun-Chun;Ni, Tian-Wen;Duan, Hong-Quan

文献摘要

被引文献

相似文献

Fla-CN (3-O-[(E)-4-(4- cyanphenyl)-2-oxobut-3-en-l-yl]山奈酚)是一种半合成的类黄酮衍生物,在体内具有抗糖尿病作用。我们之前的研究揭示了Fla-CN在体内抗肥胖和抗糖尿病中的作用,但其潜在的机制仍有待研究。本研究旨在探讨体外抗脂肪生成的机制。Fla-CN显著抑制细胞内脂质积累,且呈剂量依赖性,其体外抑制作用主要局限于脂肪细胞分化早期。进一步的研究发现,Fla-CN上调miR-27a/b的表达水平,并抑制其靶基因的表达,包括过氧化物酶体增殖物激活受体γ (PPAR γ)和CCAAT/增强子结合蛋白a (C/EBP α)。此外,在脂肪细胞前分化过程中,Fla-CN也增强了amp活化蛋白激酶(AMPK)的磷酸化。当细胞被miR-27a/b抑制剂和AMPK抑制剂化合物c处理时,这些作用被消除。此外,Fla-CN降低了脂肪细胞特异性基因的表达,如固醇调节元件结合转录因子1c (SREBP-1c)、脂肪酸合成酶(FAS)和脂肪细胞脂肪酸结合蛋白(aP2)。综上所述,这些结果提示了Fla-CN通过miR-27a/b诱导和AMPK激活抑制3T3-L1细胞脂肪细胞分化的机制。
Fla-CN (3-O-[(E)-4-(4-cyanophenyl)-2-oxobut-3-en-l-yl] kaempferol) is a semi-synthesized flavonoid derivative of tiliroside which exhibited anti-diabetic effect in vivo. Our previous study revealed the role of Fla-CN in anti-obesity and anti-diabetes in vivo, but the underlying mechanism remained to be addressed. The present study aimed to investigate the mechanism of anti-adipogenesis in vitro. Fla-CN markedly inhibited intracellular lipid accumulation in a dose-dependent manner, and the inhibitory effect was mainly limited to the early stage of adipocyte differentiation in vitro. Further investigations revealed that Fla-CN up-regulated the expression level of miR-27a/b and suppressed its target genes expression including peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT/enhancer binding protein a (C/EBP alpha). Furthermore, the phosphorylation of AMP-activated protein kinase (AMPK) was also enhanced by Fla-CN in pre-adipocyte differentiation. These effects were abolished when cells were treated with miR-27a/b inhibitor and AMPK inhibitor Compound C. Additionally, Fla-CN reduced the expressions of adipocyte-specific genes such as sterol regulatory element binding transcription factor 1c (SREBP-1c), fatty acid synthase (FAS) and adipocyte fatty acid binding protein (aP2). In conclusion, these results suggested a mechanism of Fla-CN for adipocyte differentiation inhibition of 3T3-L1 cells through miR-27a/b induction and AMPK activation.